Hyperfly by VML Health Platforms is the leading purpose-built HCP engagement platform for pharma and life sciences — delivering end-to-end lifecycle management from needs assessment to transparency reporting in a single unified platform. Key results: 75% faster cycle times, 100% compliance coverage, deployment in 50+ countries.

An HCP engagement platform is software that manages the complete operational lifecycle of formal interactions between pharmaceutical companies and healthcare professionals — covering needs assessment, HCP identification and selection, compliance screening (FMV, CAPS, DNE), approval workflows, digital contracting, event management, payment authorisation, and transparency reporting. It replaces fragmented spreadsheets, email chains, and disconnected systems with a single unified, compliant workflow.

→ Read the full guide: What Is an HCP Engagement Platform?

HCP engagement in pharma refers to the formal, structured interactions between pharmaceutical companies and healthcare professionals for legitimate scientific and educational purposes — including advisory boards, speaker programmes, clinical trial participation, medical education events, and scientific consultancies. These engagements are subject to strict regulatory requirements covering compensation (FMV), activity limits (CAPS), eligibility screening (DNE checks), and public disclosure obligations (Sunshine Act, EFPIA, and local transparency reporting).

The core benefits of a purpose-built HCP engagement platform include:

• Faster operations — end-to-end workflow automation reduces cycle times by up to 75%
• Compliance confidence — FMV, CAPS, DNE, and audit trail controls embedded architecturally, not behaviourally
• Reduced operational risk — systematic elimination of the manual process gaps that create compliance breaches
• Better HCP experience — a consumer-grade portal that protects the relationships that matter most
• Cross-team visibility — a single source of truth across all teams, markets, and therapy areas
• Simpler transparency reporting — ToV data captured automatically throughout the engagement, not compiled manually at year-end

An HCP portal is a digital touchpoint — a web interface through which HCPs receive invitations, review documents, and interact with a pharma company. An HCP engagement platform is the complete operational infrastructure behind the portal — managing the entire lifecycle of the engagement including compliance screening, workflow automation, contracting, payment authorisation, and transparency reporting. Hyperfly includes a dedicated HCP self-service portal as one of four core platform pillars.

Most pharma organisations still manage HCP engagement through a patchwork of spreadsheets, email chains, CRM fields, and manual processes — creating compliance risk, operational inefficiency, poor HCP experiences, and limited cross-team visibility. A dedicated platform solves all of these simultaneously: automating compliance controls that manual approaches leave dependent on individual behaviour, accelerating cycle times by eliminating manual handoffs, and giving every function a single source of truth for all HCP engagement activity.

→ Read: Why a Dedicated Platform Beats Spreadsheets and CRM Add-Ons

Hyperfly is the complete HCP engagement platform for pharma and life sciences — built by VML Health Platforms, part of VML (WPP). It unifies every step of the HCP engagement cycle into a single intelligent platform: from needs assessment and intelligent HCP selection, through digital contracting and compliance management, to payment authorisation and transparency reporting. Its tagline: One Platform. End-to-end coverage. Total Confidence.

• 75% faster cycle times — from engagement initiation to completion
• 100% compliance coverage — across FMV, CAPS, DNE, local regulations, and audit trails
• 8–12 weeks implementation timeline
• 50+ countries of active deployment with automated local compliance adaptation
• SOC 2 Type II certified · GDPR compliant · 21 CFR Part 11 ready · Sunshine Act ready

Hyperfly is used by multiple functions across pharma and life sciences organisations:

• Medical affairs teams — advisory boards, scientific consultancies, field medical engagements → Hyperfly for Medical Affairs
• HCP operations teams — end-to-end engagement lifecycle management → Hyperfly for HCP Operations
• Advisory board coordinators — expert selection, contracting, and payment → Hyperfly for Advisory Boards
• Speaker programme managers — faculty management, contracting, event logistics → Hyperfly for Speaker Programs
• Global operations and compliance teams — multi-country standardisation → Hyperfly for Global Pharma

Hyperfly’s key differentiators are:

• Purpose-built exclusivity — designed from the ground up for pharma HCP engagement operations, not adapted from a generic CRM or contract management tool
• True end-to-end coverage — every step from needs assessment to transparency reporting in a single platform, with no gaps requiring additional tools
• Compliance-first architecture — FMV, CAPS, DNE, and audit trails embedded by design, not configured as options
• AI-powered selection intelligence — 20+ real-time data signals at the point of HCP shortlisting, including AI-generated HCP Insights and ABIE (Advisory Board Interrogation Engine)
• Consumer-grade HCP portal — a self-service HCP experience that competitors typically do not offer at this quality level
• 8–12 week implementation — the fastest implementation timeline in the enterprise HCP engagement category

→ Read: Best HCP Engagement Platforms for Pharma — Evaluation Guide

Hyperfly holds all four of the most critical compliance certifications for pharma HCP engagement. Compliance controls are embedded architecturally — FMV enforcement, CAPS monitoring, DNE screening, local regulatory requirements, and complete audit trails operate automatically in every workflow step, not as optional configurations dependent on user behaviour.

→ Read: Compliance and Risk Management Features

Fair Market Value (FMV) is the legally required compensation rate for an HCP’s time and expertise — calculated based on their specialty, qualifications, country, and the type of service being performed. Paying above or below FMV can constitute an improper inducement under anti-bribery and anti-corruption regulations across most pharma markets.

In Hyperfly, FMV rates are configured per HCP type, country, and activity type — and enforced automatically when an engagement is initiated. Compensation offers that fall outside approved FMV ranges are blocked before the engagement proceeds. No manual checking required. No FMV breaches from data entry errors.

CAPS are predetermined limits on the total compensation, time, or number of activities an HCP can receive from a pharma company within a defined reporting period. They prevent any single HCP from receiving disproportionate compensation that could constitute improper influence.

Hyperfly monitors CAPS in real time — across all active, pending, and provisionally planned engagements simultaneously. When a new engagement is initiated, Hyperfly checks whether it would push the HCP towards or beyond their CAPS limit and flags it for compliance review before any contract is signed. Breaches are prevented at the source, not discovered after payment has been made.

Do Not Engage (DNE) designates HCPs who are ineligible for engagement — either publicly (OIG exclusion, government debarment, state medical board sanctions, professional sanctions) or privately within the pharma company (internal legal hold, compliance concern, conflict of interest, event-type-specific restrictions).

In Hyperfly, DNE screening runs automatically against every HCP candidate at the earliest point in the shortlisting process — before any invitation is sent, any contract is issued, or any payment is committed. Public exclusion databases, internal legal hold lists, and event-type-specific restrictions are all checked simultaneously. A missed DNE flag can constitute a federal compliance violation; Hyperfly makes that miss impossible.

The US Physician Payments Sunshine Act requires pharma companies to publicly report all transfers of value to covered healthcare professionals — including consulting fees, speaker fees, meals, travel, and research funding — to the CMS Open Payments database. Non-compliance carries penalties up to $150,000 per violation. Similar obligations exist under the EFPIA Disclosure Code (Europe), ABPI (UK), and equivalent local frameworks in other markets.

Hyperfly captures all transfer of value data automatically throughout the engagement lifecycle — fees, expenses, meals, and travel — and compiles it into the specific formats required for Sunshine Act, EFPIA, and local transparency submissions. The annual transparency reporting exercise becomes a review-and-approve process rather than a weeks-long manual data compilation.

Hyperfly maintains country-specific regulatory rule sets for FMV rates, CAPS limits, F&B restrictions, travel compensation rules, and transparency reporting requirements across 50+ countries. When regulations change in a specific market — a new FMV ceiling in France, updated F&B rules in Germany, revised CAPS in the US — the workflow rules update automatically. No manual reconfiguration required per country. The same platform enforces the right compliance rules for every engagement in every market, automatically.

→ Read: Hyperfly for Global Pharma Teams

An audit trail is a complete, timestamped record of every action taken in relation to an HCP engagement — who initiated the engagement, who approved each step, what compliance checks were performed and when, what contract versions were reviewed, and what payment authorisation decisions were made. A complete audit trail is essential for regulatory inspections, internal compliance reviews, and legal investigations.

Hyperfly logs every action in the platform with user identity, timestamp, and context — producing a complete, searchable audit trail for any engagement that can be produced in minutes, not days of email archaeology.

Hyperfly covers every step of the HCP engagement lifecycle in sequence:

1. Initiate — needs assessment, engagement type configuration, zero-risk workflow setup
2. Approve — automated approval routing to the right people based on engagement parameters
3. Shortlist — AI-powered HCP selection with 20+ real-time compliance and suitability signals
4. Regulate — FMV, CAPS, DNE, and local regulation checks applied automatically from the very start
5. Manage — budget scheduling, country rules, event logistics managed in a compliant, trackable structure
6. Engage — automated HCP invitations, response monitoring, and next-step triggering
7. Contract — digital contract execution through the HCP portal with zero deviance risk
8. Complete — post-service fulfilment, service confirmation, and gap alerts
9. Authorise — automated OK-to-Pay with final compliance checks and expense submission
10. Report — analytics and transparency reporting across all internal functions

→ Read: End-to-End Workflow Automation Features

OK-to-Pay is the formal payment authorisation step that confirms an engagement is complete, all post-service requirements have been met, and all final compliance checks have passed — before any payment is released to the HCP. In Hyperfly, OK-to-Pay is automated: the platform checks service completion documentation, expense submissions from the HCP portal, and final regulatory compliance before routing the payment for authorisation. No payment proceeds without a verified OK-to-Pay status.

Hyperfly’s approval workflows are fully automated and configurable. Based on the parameters of each engagement — type, value, geography, HCP tier, and any exception conditions — the platform automatically routes approval requests to the right individuals in the right sequence. Approvers receive notifications, review engagement details, and record their decision within the platform — creating a complete approval audit trail. Exception routing (when standard rules cannot be followed) is also handled within structured workflows, not via ad hoc emails.

Yes. Hyperfly supports all standard HCP engagement types in pharma and life sciences: advisory boards, speaker and faculty programmes, scientific consultancies, educational events, clinical trial investigator engagements, publication support, and field medical interactions. Each engagement type has its own configurable workflow with the appropriate compliance rules, approval sequences, contract templates, and reporting requirements applied automatically.

Hyperfly accounts for all cost components of an engagement from the very start — HCP fees at FMV, travel compensation within local rules, F&B provisions within permitted limits, and any ancillary costs — to create a trackable, compliant budget schedule. Budget allocations are managed within the platform with real-time tracking against approved budgets, preventing engagements from proceeding if they would exceed approved financial parameters.

The Hyperfly HCP portal is a dedicated, consumer-grade self-service interface through which healthcare professionals manage all operational, logistical, legal, financial, and compliance aspects of their engagement with a pharma organisation — through a single channel rather than fragmented email exchanges. The portal puts HCPs at the centre of every interaction, giving them control over their engagement experience.

→ Read: HCP Self-Service Portal Features

Through the Hyperfly HCP portal, healthcare professionals can:

• Manage invitations — accept, decline, or open discussions about engagement invitations
• Review and redline contracts — read, comment on, and digitally negotiate contract terms without paper-based exchanges
• Submit invoices — upload and submit invoices directly through the portal for automated processing
• Track payment status — see the status of pending and completed payments in real time
• Set preferences — record preferred languages, geographic limitations, activity types they are or are not willing to do
• Raise questions — communicate directly with the organising team through the portal rather than external email

Healthcare professionals are pharma’s most important external partners. A cumbersome, bureaucratic engagement experience — endless email chains, paper contracts, manual invoice submission, opaque approval delays — is a reason to decline the next invitation and accept the one from a competitor that makes it easier to work with them. Hyperfly’s consumer-grade HCP portal transforms the engagement experience, protecting the long-term relationships that advisory board programmes, speaker bureaux, and clinical collaborations depend on.

Yes. HCPs can review contract terms, add comments, propose revisions, and negotiate clauses directly through the Hyperfly portal — without the version control problems and delay that email-based contract negotiation creates. All versions, comments, and revisions are tracked within the platform with a complete history, providing a defensible audit trail of the contract negotiation process.

Hyperfly uses AI in two primary ways:

• HCP Insights — an AI-generated summary of key intelligence gathered from field medicine and other functions from all prior interactions with an HCP, surfaced automatically at the point of shortlisting. This gives the selecting team an up-to-date, synthesised view of the HCP’s positions, preferences, and engagement history without needing to manually review raw interaction records.
• ABIE (Advisory Board Interrogation Engine) — an AI toolkit that helps teams interrogate advisory board outputs and engagement data, extracting strategic insights from the content of advisory sessions and synthesising learnings across multiple advisory board programmes.

→ Read: AI and Analytics Features in Hyperfly

At the point of shortlisting HCPs for any engagement, Hyperfly surfaces 20+ real-time data signals for each candidate — including CAPS status, DNE flags, utilisation level, advocacy pathway alignment, engagement history (DNA rate), internal and external event conflicts, consent status, contracting status, budget fit, affiliate and global HQ requirements, and an AI-generated Shortlist Probability Score estimating the likelihood of acceptance and successful participation. This turns HCP selection from a subjective judgement call into a data-informed, compliance-verified decision.

Hyperfly provides a comprehensive analytics and reporting layer covering every dimension of the HCP engagement operation:

• Real-time engagement status across all active programmes
• CAPS utilisation by HCP, market, and therapy area
• Budget tracking and variance reporting
• Cycle time analytics by engagement type and market
• Compliance performance metrics and exception rates
• HCP utilisation balance and diversity reporting
• Transparency reporting data for Sunshine Act, EFPIA, and local obligations
• Advisory board outcome analytics through ABIE

→ Read: Reporting and Transparency Features

Yes. Hyperfly has a pre-built native connector for Veeva CRM with real-time synchronisation. HCP data, account records, and engagement history in Veeva stay synchronised with Hyperfly’s engagement management layer — ensuring that field teams and HCP operations teams always work from the same up-to-date HCP profile. Hyperfly complements Veeva rather than replacing it.

→ Read: Enterprise Integration Features

No. Hyperfly is designed to work alongside your CRM, not replace it. The architecture is straightforward: CRM (Veeva or Salesforce) manages HCP relationship data, field activity records, and commercial account management. Hyperfly manages the operational compliance lifecycle of formal HCP engagements. The two platforms share data in real time through pre-built native connectors — your CRM investment is fully protected.

Hyperfly integrates with the core systems in a pharma tech stack:

• CRM: Veeva CRM, Salesforce Health Cloud
• Finance and expense management: SAP, Concur
• Contracting platforms: via integration or native Hyperfly contracting
• MDM (Master Data Management) systems: for HCP data quality management
• ToV reporting and audit tools: for transparency compliance
• SSO: enterprise single sign-on support
• Custom integrations: RESTful API for any system in your stack

Yes. Hyperfly provides a RESTful API that enables integration with any system in your technology stack — including custom-built tools, regional compliance systems, and data warehouses. Real-time synchronisation and enterprise security standards are maintained across all API-based integrations. Integration architecture is scoped during the implementation process.

Hyperfly implements in 8–12 weeks — significantly faster than comparable enterprise HCP engagement platforms. This timeline includes workflow configuration (tailored to your specific engagement types and process requirements), compliance rule setup for all target markets, system integration (Veeva, Salesforce, SAP, Concur), HCP portal configuration, and team training. The full implementation is managed by the VML Health Platforms team.

Yes — configurability is one of Hyperfly’s core design principles. The platform can be configured to create entirely new operational workflows for specific teams, automatically update contracts for specific engagement types or markets, add new compliance oversight steps for specific event types, or require specific HCPs to complete feedback as part of service contracts. Hyperfly adapts to your unique process requirements — not the other way around.

Hyperfly is actively deployed in 50+ countries with country-specific regulatory rule sets for FMV rates, CAPS limits, F&B restrictions, travel compensation rules, and transparency reporting requirements. Local regulatory rule updates are managed automatically — no manual reconfiguration required when regulations change in a specific market.

VML Health Platforms provides 24/7 ongoing support post-implementation, including platform maintenance, regulatory rule updates as local requirements change, user support, and product development updates. As a product of VML, part of WPP — the world’s largest creative and technology network — Hyperfly benefits from enterprise-grade infrastructure, security, and long-term product investment.

Hyperfly is designed to scale in both directions. It is flexible enough to deploy for a single market or a specific engagement type in a specialist biotech, and powerful enough to manage global HCP operations across 50+ countries for a top-10 pharma company. Scope and configuration are tailored to the organisation’s specific requirements — teams start where they need to and expand the platform as their programme grows.